Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease

Published:2014-12 Issue:12 Volume:20 Page:2247-2259
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Dotan Iris,Ron Yulia,Yanai Henit,Becker Stuart,Fishman Sigal,Yahav Lior,Ben Yehoyada Merav,Mould Diane R.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference59 articles.

1. A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

2. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

3. Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

4. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

5. Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT-based body composition parameters predict the loss of response to infliximab in patients with Crohn's disease;The American Journal of the Medical Sciences;2024-09

2. Therapeutic options for children and young people with moderate-to-severe ulcerative colitis;Frontline Gastroenterology;2024-07-13

3. Impact of Obesity and Metabolic Syndrome on IBD Outcomes;Digestive Diseases and Sciences;2024-06-12

4. Biomarkers predicting the effect of anti‐TNF treatment in paediatric and adult inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2024-05-02

5. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3